Structure basis for identification of the N-terminal domain of coronavirus nucleocapsid protein as a potent antiviral target for drug development
碩士 === 國立中興大學 === 基因體暨生物資訊學研究所 === 101 === Coronaviruses (CoV) cause a number of diseases often causing significant economic and health-related consequences. In humans, they are responsible for the common cold and severe acute respiratory syndrome (SARS), the first pandemic of the 21st century. The...
Main Authors: | Shing-Yen Lin, 林省言 |
---|---|
Other Authors: | Ming-Hon Hou |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/20304455333449533273 |
Similar Items
-
Development of antiviral drug by modulating the protein-protein interactions of the N-terminal domain of MERS-CoV nucleocapsid protein
by: Yong-Sheng Wang, et al.
Published: (2016) -
Identification of the nucleocapsid proteins of influenza virus H1N1 and human coronavirus OC43 as a potential antiviral target
by: Chia-Ling Liu, et al.
Published: (2011) -
Characterization of Two Monoclonal Antibodies That Recognize Linker Region and Carboxyl Terminal Domain of Coronavirus Nucleocapsid Protein.
by: Xin Zhang, et al.
Published: (2016-01-01) -
Characterization of the C-terminal domain of human coronavirus 229E nucleocapsid protein in RNA-binding and oligomerization
by: Ya-Li Chiu, et al. -
The Coronavirus Nucleocapsid Is a Multifunctional Protein
by: Ruth McBride, et al.
Published: (2014-08-01)